News

Novartis Expands Radioligand Therapy Manufacturing in US

Yuvraj — Thu, 14 May 2026 13:01:19 +0000

Swiss pharmaceutical company Novartis has started construction of a new manufacturing facility in Denton, Texas, as part of its previously announced $23 billion investment plan aimed at expanding research and production operations across the United States. The project, expected to be completed in 2028, will become the company’s first manufacturing site in Texas and its […]

The post Novartis Expands Radioligand Therapy Manufacturing in US first appeared on World Pharma Today.

Angelini Pharma Expands US Presence with Catalyst Pharmaceuticals Acquisition

Yuvraj — Tue, 12 May 2026 08:55:49 +0000

Angelini Pharma has finalized a definitive agreement to acquire Catalyst Pharmaceuticals for an equity value of approximately €3.5bn ($4.1bn). This move marks a strategic entry into the US market for the company, further consolidating its operational focus on brain health and the treatment of complex conditions. The transaction, which has received unanimous approval from the […]

The post Angelini Pharma Expands US Presence with Catalyst Pharmaceuticals Acquisition first appeared on World Pharma Today.

Are Glutathione Injections in NYC Worth It? A Complete Guide

Yuvraj — Mon, 11 May 2026 09:37:43 +0000

When whatever you do to your skin makes it look dull, uneven, or tired, you are not alone. Many people in New York look for easy wellness solutions that could achieve a healthier and brighter look on the inside. This is one of the reasons why searches for glutathione injections New York have become more frequent […]

The post Are Glutathione Injections in NYC Worth It? A Complete Guide first appeared on World Pharma Today.

Fujifilm Advances Drug Discovery with New Cyclic Peptide Screening Platform

Yuvraj — Sat, 09 May 2026 07:05:46 +0000

FUJIFILM Corporation has developed a new screening methodology aimed at identifying cyclic peptides with high affinity toward membrane proteins, including complex multi-pass transmembrane proteins that have traditionally been difficult to target in drug discovery research. The company announced that the technology will be presented during the TIDES USA exhibition taking place from May 11 to […]

The post Fujifilm Advances Drug Discovery with New Cyclic Peptide Screening Platform first appeared on World Pharma Today.

UCB Acquires Candid Therapeutics in a $2 Billion-Plus Deal to Strengthen Immunology Pipeline

Yuvraj — Wed, 06 May 2026 12:17:16 +0000

Belgian pharmaceutical company UCB is making a substantial move to expand its immunology pipeline, entering into a multi-billion dollar agreement to acquire Candid Therapeutics a clinical-stage biotechnology company working on therapies designed to treat autoimmune disorders by resetting the immune system. The UCB Candid Therapeutics deal involves an upfront payment of $2 billion to Candid’s […]

The post UCB Acquires Candid Therapeutics in a $2 Billion-Plus Deal to Strengthen Immunology Pipeline first appeared on World Pharma Today.

BeOne Signs $2B Trispecific Antibody Deal with Huahui Health

Yuvraj — Mon, 04 May 2026 10:25:34 +0000

BeOne Medicines has entered into a high-value agreement with Huahui Health, committing $20 million upfront to secure an exclusive option for a preclinical trispecific antibody candidate developed by the Chinese biotech firm. The asset, identified as HH160, targets PD-1, CTLA-4 and VEGF-A, positioning it within a growing class of multi-target oncology therapies. The arrangement gives […]

The post BeOne Signs $2B Trispecific Antibody Deal with Huahui Health first appeared on World Pharma Today.

Glass vs Polymer: Choosing the Right Material for Parenteral Packaging

Yuvraj — Fri, 01 May 2026 13:34:59 +0000

In the pharmaceutical industry, material selection plays a critical role in ensuring the safety, stability, and efficacy of injectable drugs. Parenteral products those administered via injection, infusion, or implantation require highly specialized packaging to maintain sterility and prevent contamination. Among the most widely used materials for this purpose are glass and polymer-based systems. Each offers […]

The post Glass vs Polymer: Choosing the Right Material for Parenteral Packaging first appeared on World Pharma Today.

FDA Advances Real-Time Clinical Trials With AstraZeneca, Amgen

Yuvraj — Fri, 01 May 2026 10:18:20 +0000

The U.S. Food and Drug Administration has unveiled a new regulatory initiative to enable real-time clinical trials, marking a structural shift in how drug development data is reviewed. The program, already supported by AstraZeneca and Amgen, introduces a model where safety and efficacy data are transmitted continuously to regulators rather than submitted after trial completion. […]

The post FDA Advances Real-Time Clinical Trials With AstraZeneca, Amgen first appeared on World Pharma Today.

Chiesi Advances Rare Disease Portfolio with KalVista Deal

Yuvraj — Fri, 01 May 2026 10:13:17 +0000

Chiesi Group has entered into a definitive agreement to acquire KalVista Pharmaceuticals, marking a significant step in strengthening its rare disease portfolio. Announced on 29 April 2026, the transaction will see Chiesi acquire all outstanding shares of KalVista for $27.00 per share in cash, valuing the deal at approximately $1.9bn. The agreement, unanimously approved by […]

The post Chiesi Advances Rare Disease Portfolio with KalVista Deal first appeared on World Pharma Today.

AstraZeneca UK Investment Resumes with £300m Commitment

Yuvraj — Fri, 01 May 2026 09:06:42 +0000

In a reversal of its earlier stance, AstraZeneca has confirmed a £300m commitment to the UK, marking a renewed push into domestic operations after previously halting major projects. The announcement, delivered in Parliament by Keir Starmer, signals a shift in direction following concerns over the UK’s business climate, including access to new medicines through the […]

The post AstraZeneca UK Investment Resumes with £300m Commitment first appeared on World Pharma Today.